Visualization of efficacy of recombinant factor FVIIa in a pelvic fracture patient.
Department of Emergency and Critical Care Medicine, Tokyo Medical University Hospital, Tokyo, Japan.
Mariko
M
Noda
Junya
J
Morozumi
Shiro
S
Mishima
Hirokazu
H
Sasaki
Tetsuo
T
Yukioka
Shoichi
S
Ohta
D000058:Accidental Falls; D000328:Adult; D000792:Angiography; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004621:Embolization, Therapeutic; D015942:Factor VIIa / Q000627:therapeutic use*; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000175:diagnosis / Q000628:therapy; D006406:Hematoma / Q000000981:diagnostic imaging / Q000628:therapy*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007083:Iliac Artery / Q000000981:diagnostic imaging / Q000187:drug effects / Q000293:injuries*; D007275:Injections, Intravenous; D015601:Injury Severity Score; D008297:Male; D009104:Multiple Trauma / Q000175:diagnosis / Q000628:therapy; D010384:Pelvic Bones / Q000000981:diagnostic imaging / Q000293:injuries*; D011994:Recombinant Proteins / Q000627:therapeutic use; D018570:Risk Assessment; D014057:Tomography, X-Ray Computed; D014193:Trauma Centers; D016896:Treatment Outcome
D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa